Octant Bio
Mapping a New Universe of Medicine
Los Angeles, United States · Founded 2017 · $289.9M raised
- Headquarters
- Los Angeles, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- octant.bio
- Total Funding
- $289.9M
- Last Round
- $175.0M Series COct 2025
- Rounds
- 4
About
Octant merges next-generation biology, chemistry, and computation to engineer precision small molecule therapeutics targeting complex cellular mechanisms that cause disease, with a focus on protein misfolding correctors. The platform enables high-throughput design, build, test, learn cycles. Pipeline includes programs for RHO-adRP (Phase 1), Fabry disease, neurodegeneration, oncology, metabolism, and immunology.
Summary
Octant Bio is a Healthcare company based in Los Angeles, United States, founded in 2017. It has raised $289.9M in total across 4 rounds, most recently a $175.0M Series C round in Oct 2025. Investors include Andreessen Horowitz, Catalio Capital Management and Allen & Co..
Tech & App Stack
12 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...